{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:13:56Z","timestamp":1788610436979,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.lfs.2022.120845","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:01:08Z","timestamp":1659168068000},"page":"120845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The modulatory effect of sodium molybdate against cisplatin-induced CKD: Role of TGF-\u03b2\/Smad signaling pathway"],"prefix":"10.1016","volume":"306","author":[{"given":"Esraa G.","family":"El-Waseif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha H.","family":"Sharawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Suddek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl 1","key":"10.1016\/j.lfs.2022.120845_bb0005","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"3 Suppl 3","key":"10.1016\/j.lfs.2022.120845_bb0010","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.ajkd.2008.07.048","article-title":"Conceptual model of CKD: applications and implications","volume":"53","author":"Levey","year":"2009","journal-title":"Am.J.Kidney Dis."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0015","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"issue":"8","key":"10.1016\/j.lfs.2022.120845_bb0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.mehy.2004.11.048","article-title":"Adjuvant strategies for prevention of glomerulosclerosis","volume":"67","author":"McCarty","year":"2006","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000368458","article-title":"Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data","volume":"39","author":"Tomino","year":"2014","journal-title":"KidneyBlood Press.Res."},{"key":"10.1016\/j.lfs.2022.120845_bb0035","first-page":"ix26","article-title":"How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease","volume":"22 Suppl 9","author":"Metcalfe","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0040","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.120845_bb0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fimmu.2015.00340","article-title":"Cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities","volume":"6","author":"Gajjala","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0050","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0055","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1 Pt 2","key":"10.1016\/j.lfs.2022.120845_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.HYP.31.1.181","article-title":"Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis","volume":"31","author":"Border","year":"1998","journal-title":"Hypertension"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120845_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cytogfr.2005.09.005","article-title":"Role of anti-TGF-\u03b2 antibodies in the treatment of renal injury","volume":"17","author":"Gagliardini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","article-title":"Fibroblasts and myofibroblasts in renal fibrosis","volume":"92","author":"Meran","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"issue":"6488","key":"10.1016\/j.lfs.2022.120845_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-\u03b2 receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.lfs.2022.120845_bb0080","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1074\/jbc.C100008200","article-title":"Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation","volume":"276","author":"Ebisawa","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6958","key":"10.1016\/j.lfs.2022.120845_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lfs.2022.120845_bb0090","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2337\/db09-1631","article-title":"Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0095","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","article-title":"Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation","volume":"6","author":"Kavsak","year":"2000","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0100","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.2004121070","article-title":"Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7","volume":"16","author":"Wang","year":"2005","journal-title":"J.Am.Soc.Nephrol."},{"key":"10.1016\/j.lfs.2022.120845_bb0105","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.2741\/3057","article-title":"Smad7 as a therapeutic agent for chronic kidney diseases","volume":"13","author":"Lan","year":"2008","journal-title":"Front.Biosci."},{"key":"10.1016\/j.lfs.2022.120845_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.lfs.2022.120845_bb0115","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J.Nephrol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120845_bb0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.lfs.2022.120845_bb0135","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"issue":"11","key":"10.1016\/j.lfs.2022.120845_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142225","article-title":"Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study","volume":"10","author":"Bhat","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0145","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0150","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00204-014-1239-1","article-title":"Mitochondrial dysregulation and protection in cisplatin nephrotoxicity","volume":"88","author":"Yang","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2022.120845_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2022.120845_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9681(62)90101-7","article-title":"Abnormal trace metals in man\u2013nickel","volume":"15","author":"Schroeder","year":"1962","journal-title":"J. Chronic Dis."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0165","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0002-8223(21)03381-2","article-title":"Molybdenum, nickel, cobalt, vanadium, and strontium in total diets","volume":"87","author":"Pennington","year":"1987","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.lfs.2022.120845_bb0170","series-title":"Trace Elements in Human And Animal Nutrition","author":"Underwood","year":"2012"},{"key":"10.1016\/j.lfs.2022.120845_bb0175","first-page":"S180","article-title":"Molybdenum supply and status in animals and human beings","volume":"1","author":"Anke","year":"1985","journal-title":"Nutr. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-2797(02)00254-5","article-title":"Sodium molybdate improves the phagocytic function in alloxan-induced diabetic rats","volume":"145","author":"Panneerselvam","year":"2003","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120845_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cccn.2004.03.005","article-title":"Effect of sodium molybdate on the status of lipids, lipid peroxidation and antioxidant systems in alloxan-induced diabetic rats","volume":"345","author":"Panneerselvam","year":"2004","journal-title":"Clin.Chim.Acta"},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00250285","article-title":"Regulation of redox states of plasma proteins by metabolism and transport of glutathione and related compounds","volume":"6","author":"Inoue","year":"1987","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.lfs.2022.120845_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jtemb.2014.07.002","article-title":"Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation","volume":"29","author":"Ale-Ebrahim","year":"2015","journal-title":"J.Trace Elem.Med.Biol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1699-0463.1990.tb05039.x","article-title":"Atubular glomeruli in cisplatin-induced chronic interstitial nephropathy. An experimental stereological investigation","volume":"98","author":"Marcussen","year":"1990","journal-title":"APMIS"},{"key":"10.1016\/j.lfs.2022.120845_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118454","article-title":"Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats","volume":"260","author":"Sharawy","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120845_bb0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2022.120845_bb0230","series-title":"Theory And Practice of Histo-logical Techniques ed 2 Churchill-Livingstone","author":"Bancroft","year":"1982"},{"key":"10.1016\/j.lfs.2022.120845_bb0235","series-title":"Creatinine clearance","author":"Shahbaz","year":"2019"},{"key":"10.1016\/j.lfs.2022.120845_bb0240","series-title":"Clinical Chemistry, Principles And Technics","author":"Henry","year":"1964"},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.trre.2011.10.002","article-title":"Proteinuria: detection and role in native renal disease progression","volume":"26","author":"Gorriz","year":"2012","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.lfs.2022.120845_bb0250","series-title":"Book Review: Tietz Textbook of Clinical Chemistry","author":"Hardy","year":"2000"},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1258\/0007142991902295","article-title":"Redox imbalance in the critically ill","volume":"55","author":"Gutteridge","year":"1999","journal-title":"Br. Med. Bull."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0260","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/41.12.1819","article-title":"Lipid peroxidation and antioxidants as biomarkers of tissue damage","volume":"41","author":"Gutteridge","year":"1995","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2022.120845_bb0265","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3629","article-title":"Analysis of generalized fibrosis in mouse tissue sections with Masson's trichrome staining","volume":"10","author":"Van De Vlekkert","year":"2020","journal-title":"Bio-protocol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0270","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/codi.13400","article-title":"The use of Masson's trichrome staining, second harmonic imaging and two-photon excited fluorescence of collagen in distinguishing intestinal tuberculosis from Crohn's disease","volume":"18","author":"Mao","year":"2016","journal-title":"Color. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2022.120845_bb0275","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0280","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2165\/11316640-000000000-00000","article-title":"Cisplatin overdose","volume":"32","author":"Tsang","year":"2009","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.lfs.2022.120845_bb0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.08070715","article-title":"Long\u2013term renal outcomes after cisplatin treatment","volume":"11","author":"Latcha","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COC.0000000000000301","article-title":"Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy","volume":"41","author":"Faig","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0300","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","article-title":"Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity","volume":"8","author":"Ries","year":"1986","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1293\/tox.2018-0049","article-title":"Dimethyl fumarate ameliorates cisplatin-induced renal tubulointerstitial lesions","volume":"32","author":"Sasaki","year":"2019","journal-title":"J. Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120845_bb0310","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2015010079","article-title":"Three-dimensional morphology by multiphoton microscopy with clearing in a model of cisplatin-induced CKD","volume":"27","author":"Torres","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-016-1332-5","article-title":"Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats","volume":"390","author":"Abdel-Daim","year":"2017","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.07.001","article-title":"NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation","volume":"383","author":"Li","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2022.120845_bb0325","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0330","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.2000.278.5.F726","article-title":"Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis","volume":"278","author":"Shiraishi","year":"2000","journal-title":"Am.J.Physiol.Renal Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120845_bb0335","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","article-title":"Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide","volume":"12","author":"Davis","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0340","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00512.2015","article-title":"Repeated administration of low-dose cisplatin in mice induces fibrosis","volume":"310","author":"Sharp","year":"2016","journal-title":"Am.J.Physiol.Renal Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0345","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ki.2015.327","article-title":"Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition","volume":"89","author":"Katagiri","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.120845_bb0350","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"<sb:contribution><sb:title>Braz.<\/sb:title><\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>J. Nephrol.<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120845_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cccn.2004.03.005","article-title":"Effect of sodium molybdate on the status of lipids, lipid peroxidation and antioxidant systems in alloxan-induced diabetic rats","volume":"345","author":"Panneerselvam","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.lfs.2022.120845_bb0360","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jn\/122.4.1036","article-title":"Molybdenum requirement of female rats","volume":"122","author":"Wang","year":"1992","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0365","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtemb.2010.12.003","article-title":"Protective effects of sodium molybdate on carbon tetrachloride-induced hepatotoxicity in rats","volume":"25","author":"Eidi","year":"2011","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120845_bb0370","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","article-title":"Obstructive nephropathy and renal fibrosis","volume":"283","author":"Klahr","year":"2002","journal-title":"Am.J.Physiol.Renal Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0375","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1523-1755.1998.00767.x","article-title":"In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity","volume":"53","author":"Baliga","year":"1998","journal-title":"Kidney Int."},{"issue":"15","key":"10.1016\/j.lfs.2022.120845_bb0380","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-\u03baB\u2014a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2022.120845_bb0385","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1046\/j.1523-1755.2001.00043.x","article-title":"Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury","volume":"60","author":"Deng","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.120845_bb0390","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.freeradbiomed.2018.11.006","article-title":"N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation","volume":"130","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0395","doi-asserted-by":"crossref","first-page":"F162","DOI":"10.1152\/ajprenal.00463.2018","article-title":"Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration","volume":"316","author":"Sharp","year":"2019","journal-title":"Am.J.Physiol.Renal Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0400","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1152\/ajprenal.00636.2017","article-title":"Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease","volume":"315","author":"Sharp","year":"2018","journal-title":"Am.J.Physiol.Renal Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0405","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1124\/jpet.111.191247","article-title":"Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor \u03baB signaling","volume":"341","author":"Liu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2022.120845_bb0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and molecular mechanisms of kidney fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jfda.2019.10.001","article-title":"Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model","volume":"28","author":"Lee","year":"2020","journal-title":"J. Food Drug Anal."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-019-01734-y","article-title":"Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling","volume":"393","author":"Maghmomeh","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120845_bb0425","unstructured":". M Ale-Ebrahim A Eidi P Mortazavi . The protective effects of sodium molybdate on cholestatic liver-cellular approach. BDL.1:0.21."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-019-01734-y","article-title":"Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling","volume":"393","author":"Maghmomeh","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120845_bb0435","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000045217","article-title":"Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy","volume":"80","author":"Razzaque","year":"1998","journal-title":"Nephron"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120845_bb0440","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2004.04.008","article-title":"Effects of lipopolysaccharide on the appearance of macrophage populations and fibrogenesis in cisplatin-induced rat renal injury","volume":"56","author":"Yamate","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2022.120845_bb0445","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2012.03.019","article-title":"Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation","volume":"683","author":"Park","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120845_bb0450","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfs496","article-title":"Acute and chronic effects of dietary sodium restriction on renal tubulointerstitial fibrosis in cisplatin-treated rats","volume":"28","author":"Park","year":"2013","journal-title":"Nephrol.Dial.Transplant."},{"issue":"1","key":"10.1016\/j.lfs.2022.120845_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086553","article-title":"Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner","volume":"9","author":"Bae","year":"2014","journal-title":"PloS one"},{"issue":"10","key":"10.1016\/j.lfs.2022.120845_bb0460","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","article-title":"TGF-beta signaling in renal disease","volume":"13","author":"B\u00f6ttinger","year":"2002","journal-title":"J.Am.Soc.Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120845_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response","volume":"85","author":"Flanders","year":"2004","journal-title":"Int. J. Exp. Pathol."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2026.124521","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000}},{"DOI":"10.1016\/j.lfs.2026.124521","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:05:57Z","timestamp":1758402357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522005458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":92,"alternative-id":["S0024320522005458"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120845","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The modulatory effect of sodium molybdate against cisplatin-induced CKD: Role of TGF-\u03b2\/Smad signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120845"}}